Killing of Escherichia coli in the peritoneal cavity of convalescent mice; role of specific and non-specific immune mechanisms

References

1. Abernathy R S. 1957; Homologous and heterologous resistance in mice given bacterial endotoxins. Journal of Immunology 78:387–394
   [Google Scholar]
2. Dunn D L, Barke R A, Knight N B, Humphrey E W, Simmons R L. 1985; Role of resident macrophages, peripheral neutrophils and translymphatic absorption in bacterial clearance from the peritoneal cavity. Infection and Immunity 49:257–264
   [Google Scholar]
3. Galanos C, Liideritz O, Westphal O. 1969; A new method for the extraction of R lipopolysaccharides. European Journal of Biochemistry 9:245–249
   [Google Scholar]
4. Galelli A, Parant M, Chedid L. 1977; Role of radiosensitive and radioresistant cells in nonspecific resistance to infection of LPS-treated mice. Journal of the Reticuloendothelial Society 21:109–118
   [Google Scholar]
5. Horwitz M A, Silverstein S C. 1980; Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. Journal of Clinical Investigation 65:82–94
   [Google Scholar]
6. Landy M. 1956; Increase in resistance following administration of bacterial lipopolysaccharides. Annals of the New York Academy of Sciences 66:292–303
   [Google Scholar]
7. Miller J H. 1972; Experiments in molecular genetics. Cold Spring Harbor Laboratory; New York:
   [Google Scholar]
8. Parant M. 1983; Effect of LPS on nonspecific resistance to bacterial infections. Nowotny A. Beneficial effects of endotoxins Plenum Press; New York:179–196
   [Google Scholar]
9. Reed L J, Muench H. 1938; A simple method of estimating fifty per cent end-points. American Journal of Hygiene 27:493–497
   [Google Scholar]
10. Rowley D. 1955; Stimulation of natural immunity to Escherichia coli infections. Observations on mice. Lancet 1:232–234
    [Google Scholar]
11. Rowley D. 1964; Endotoxin-induced changes in susceptibility to infections. Landy M, Braun W. Bacterial endotoxins Rutgers University Press; New Brunswick, NJ:359–372
    [Google Scholar]
12. Tegtmeier B R, Andersen B R. 1983; Mechanisms of lipopolysac-charide-induced protection against Pseudomonas sepsis in granulocytopenic mice. Reviews of Infectious Diseases 5: Suppl S963–970
    [Google Scholar]
13. Vaara M, Viljanen P, Vaara T, Mâkelâ P H. 1984; An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action. Journal of Immunology 132:2582–2589
    [Google Scholar]
14. Vuopio-Varkila J, Karvonen M, Saxén H. 1987a; The protective capacity of antibodies to various outer membrane components in a systemic mouse peritonitis model caused by Escherichia coli O18: K1. Journal of Medical Microbiology. In press
    [Google Scholar]
15. Vuopio-Varkila J, Nurminen M, Pyhala L, Makela P H. 1987b; LPS-induced nonspecific resistance to systemic E. coli infection in mice. Journal of Medical Microbiology 25:197–203
    [Google Scholar]